Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.54 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PRF1 | P14222 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | PRKDC | P78527 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9199395 | 0.82 | CYP2E1 (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL2018262 | 0.80 | APP (0.61) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL1133750 | 0.80 | APP (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL7905308 | 0.80 | APP (0.68) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL9538845 | 0.80 | APP (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL1134019 | 0.80 | APP (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL1133819 | 0.80 | APP (0.54) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL70783 | 0.79 | APP (0.67) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL3630228 | 0.78 | APP (0.81) | APPCYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL278904 | 0.78 | DPP4 (0.65) | APPCYP2E1CYP3A4CYP2A6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435075-B2 | Compound, film, sensor, and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-07 | — | — | US | disclosed |
| EP-4174063-A1 | COMPOUND, FILM, SENSOR, AND ELECTRONIC DEVICE | Samsung Electronics Co., Ltd. (KR) | 2023-05-03 | — | — | EP | disclosed |
| CN-116023369-A | Compound, membrane, sensor and electronic device | 三星电子株式会社 | 2023-04-28 | — | — | CN | disclosed |
| US-20230125778-A1 | COMPOUND, FILM, SENSOR, AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125778-A1 | COMPOUND, FILM, SENSOR, AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125778-A1 | COMPOUND, FILM, SENSOR, AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| WO-2023011657-A1 | METHOD FOR DETECTING AND QUANTIFYING RNA | 纳莹(上海)生物科技有限公司 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023011658-A1 | METHOD FOR DETECTING AND QUANTIFYING RNA | 纳莹(上海)生物科技有限公司 | 2023-02-09 | — | — | WO | disclosed |
| EP-2285802-B1 | OXO-IMIDAZOLYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY | ASTEX PHARMACEUTICALS INC (US) | 2015-11-11 | — | — | EP | disclosed |
| US-8759384-B2 | Oxo-imidazolyl compounds | ASTEXPHRMACEUTICALS, INC. | 2014-06-24 | — | — | US | disclosed |
| WO-2010081904-A1 | 4 ( 1H) -PYRIDINONE DERIVATIVES AND THEIR USE AS ANTIMALARIA AGENTS | GLAXO GROUP LIMITED (GB) | 2010-07-22 | — | — | WO | disclosed |
| US-20100173891-A1 | HETEROCYCLIC COMPOUNDS, METHODS FOR THE PREPARATION THEREOF, AND USES THEREOF | HERBERT BRIAN | 2010-07-08 | — | — | US | disclosed |
| US-7700630-B2 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-20090298900-A1 | Oxo-Imidazolyl Compounds | ASTEXPHRMACEUTICALS, INC. | 2009-12-03 | — | — | US | disclosed |
| WO-2009139870-A1 | OXO-IMIDAZOLYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY | SUPERGEN, INC. | 2009-11-19 | — | — | WO | disclosed |
| US-20090105215-A1 | 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system | HERBERT BRIAN | 2009-04-23 | — | — | US | disclosed |
| US-7244745-B2 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | MEMORY PHARMACEUTICALS CORP. (US) | 2007-07-17 | — | — | US | disclosed |
| EP-1531820-A1 | ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Memory Pharmaceuticals Corporation (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20040229868-A1 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | MEMORY PHARMACEUTICALS CORP. | 2004-11-18 | — | — | US | disclosed |
| WO-2004019943-A1 | ANABASEINE DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | MEMORY PHARMACEUTICALS CORPORATION (US) | 2004-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125778-A1 | COMPOUND, FILM, SENSOR, AND ELECTRONIC DEVICE | HAX1, CYP19A1, ESR1 | APP 586/4885CYP2E1 78/4885CYP3A4 481/4885 |
| US-20040229868-A1 | Heterocyclic compounds, methods for the preparation thereof, and uses thereof | CHRNA1, CHRNA4, CHRNA3 | APP 2223/4885CYP2E1 571/4885CYP3A4 273/4885 |
| US-20090298900-A1 | Oxo-Imidazolyl Compounds | GALE, CYP51A1, GNE | APP 4844/4885CYP2E1 91/4885CYP3A4 57/4885 |
| US-20090105215-A1 | 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system | CHRNA3, CHRNA2, CHRNA5 | APP 157/4885CYP2E1 1327/4885CYP3A4 1139/4885 |
| US-20100173891-A1 | HETEROCYCLIC COMPOUNDS, METHODS FOR THE PREPARATION THEREOF, AND USES THEREOF | CHRM3, CHRNA1, CHRNA5 | APP 2290/4885CYP2E1 879/4885CYP3A4 367/4885 |
| US-12435075-B2 | Compound, film, sensor, and electronic device | HAX1, CYP19A1, ESR1 | APP 586/4885CYP2E1 78/4885CYP3A4 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.